San Francisco Biotech Trending News

There may be a solid chunk of executives in the Endpoints 100 who feel that better times are ahead for the biotech industry in 2024, but they’re still outnumbered by doubters and the undecided. This […]

Nine months after revealing that its TIGIT/PD-1 combo failed a mid-stage lung cancer study, Merck is spelling out the full results — with the combo missing all the primary and secondary endpoints. Despite the flop, […]

MENLO PARK, Calif. & CAMBRIDGE, England & SEOUL, South Korea–(BUSINESS WIRE)–Validation Data on a Novel Prognostic Test Developed by GRAIL Click here to view original post Click here to view San Francisco Biotech Networks Trending […]

The Emeryville company has cut hundreds of jobs before and during its Chapter 11 bankruptcy reorganization. Click here to view original post Click here to view San Francisco Biotech Networks Trending News

Contract for California Warehouse Workers Expires December 10 SACRAMENTO, Calif., Dec. 4, 2023 /PRNewswire/ — Teamsters at McKesson in Sacramento, Calif., have voted overwhelmingly to authorize a strike if the company fails to reach agreement […]

Ideaya and Gilead will study a potential combo in bladder cancer. The South San Francisco-based company announced Monday that it plans to test its MAT2A inhibitor in combination with Gilead’s Trodelvy in MTAP-deletion bladder cancer. […]

The company late last year moved from Menlo Park to 100,000 square feet in Fremont, which it leased for 13-1/2 years. Click here to view original post Click here to view San Francisco Biotech Networks […]

A new investment firm affiliated with ARCH Venture Partners has raised $200 million for its first fund as it seeks to back scientific research out of Japan to create new global biotech startups. AN Venture […]

The deal for the four-year-old Santa Rosa company, which will start enrolling a pivotal clinical trial early next year, includes milestone payments. Click here to view original post Click here to view San Francisco Biotech […]